0
Summaries for Patients |

Blood Clots in People with Factor V Leiden Mutation FREE

[+] Article and Author Information

The summary below is from the full report titled “Factor V Leiden and the Risk for Venous Thromboembolism in the Adult Danish Population.” It is in the 2 March 2004 issue of Annals of Internal Medicine (volume 140, pages 330-337). The authors are K. Juul, A. Tybjærg-Hansen, P. Schnohr, and B.G. Nordestgaard.


Ann Intern Med. 2004;140(5):I-50. doi:10.7326/0003-4819-140-5-200403020-00002
Text Size: A A A

What is the problem and what is known about it so far?

Blood clots sometimes occur in deep veins in the legs. Pieces of these clots, known as emboli, can break off and travel through the bloodstream, blocking arteries in the lungs. The blood clots and emboli can cause serious symptoms and death. Surgery, pregnancy, trauma, hormone therapy, and inherited blood disorders increase risks for blood clots and emboli. Factor V Leiden is one of these inherited disorders. Some studies show that it is associated with very high risks for clots. However, many researchers wonder about the actual size or amount of risks for clots and emboli among people with the defect.

Why did the researchers do this particular study?

To find out how often blood clots and emboli occur in people with the factor V Leiden mutation.

Who was studied?

9253 randomly selected adults from Denmark who were tested for factor V Leiden.

How was the study done?

Researchers asked participants about their medical history and lifestyle, gave them physical examinations, and took blood samples. They divided the participants into 3 groups based on whether they had no factor V Leiden mutations, had a single form (allele) of the factor V Leiden gene (heterozygote), or had a double form of the gene (homozygote). They followed everyone for up to 23 years to see who got clots or emboli. They used hospital records and national databases of hospital discharges and deaths to confirm diagnoses. They then calculated the risk for getting clots for each of the 3 groups. They also examined whether people with certain characteristics, such as obesity and older age, had higher risks for clots.

What did the researchers find?

Heterozygotes and homozygotes for factor V Leiden had about 3 and 18 times higher risks for clots and emboli than people without factor V Leiden mutations. The risks for clots and emboli over a 10-year period were about 1% among heterozygote people and 3% among homozygote people who did not smoke, were not overweight, and were younger than 40 years of age. The risks over a 10-year period were 10% in heterozygote people and 51% in homozygote people who smoked, were overweight, and were over 60 years of age.

What were the limitations of the study?

The researchers did not know whether any of the participants were taking blood thinners that might decrease risks for blood clots.

What are the implications of the study?

Blood clots and emboli associated with factor V Leiden mutations are important, but the risks for them are lower than previously reported.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)